Centessa Pharmaceuticals plc
live · Yahoo FinanceLimited buying: $69.5M bought (counted up to $5.0M); 10 distinct insiders. Holding it back: largest buyer: Weinhoff Gregory M (CFO), 43% of the dollars.
Score, not a recommendation.
partial dataAn input is missing, usually the market cap or the price history. A missing input counts as neutral in the score and is never estimated. Price history is incomplete; missing inputs count as neutral in the score.
same price, one day All 14 purchases were at $20.00 on 2021-06-02. That pattern also occurs in IPO or conversion subscriptions, which are not open-market conviction buying.
Price and insider purchases
Live chart from Yahoo Finance, loaded through this server; our daily closes when it is unavailable.
Loading price history…
How the score adds up
How each input is counted →| Input | Strength | Points |
|---|---|---|
| $69.5M bought (counted up to $5.0M)The dollars the insiders bought, a purchase reported jointly counted once, counted from $131. Each tenfold adds 12.4 points, up to $5.0M; more adds nothing. The bar is empty at $10.0K and full at $5.0M. | 100% | +57 |
| 10 distinct insidersHow many different insiders bought. Each extra insider adds less than the one before (the points follow the log of the count: 4.3 per doubling). The bar is full at 10 insiders. | 100% | +14 |
| No CEO among the buyersWhether the chief executive is among the buyers: 10.6 points when yes. | 0% | +0 |
| Stock 0% below its 1-year highHow far the stock had fallen from its highest close of the past year, at the close before the buying. Every 10% of fall adds 1.9 points. A fall beyond 30% adds nothing more. The bar is full at a 30% fall. | 0% | +0 |
| 0 days from first to last purchaseDays between the first and the last purchase. Each day takes off 0.11 points: buying close together keeps more. The bar is empty at 60 days. | 100% | +0 |
| Routine or plan purchases: 0% of the dollars | 100% | +0 |
| Largest buyer: Weinhoff Gregory M (CFO), 43% of the dollars | 63% | -5 |
| Match scoreA score from 0 to 100 worked out from the dollars bought, the number of insiders, whether a CEO bought, how far the stock had fallen, how spread out the purchases were and how much came from one buyer. Its weights were calibrated on past clusters. It is the default ranking of the lists and it decides which clusters get the AI review. It describes the buying; it is not a forecast. | 66 | |
| Pipeline flagsPoints taken off because the filings themselves show this buying was an offering, a plan or a 10b5-1 programme. Used only when there is no AI review; from Form 4 footnotes, 8-K filings and prices. (IPO or offering) | -14 | |
| Insider ScoreThe number from 0 to 100 shown on each cluster and used to rank the lists. By default it is the match score, plus the points of the AI review when there is one. It describes the buying; it is not a forecast or a recommendation. | 52 | |
Why are they buying?
No explanation has been generated for this cluster. The filings in the table below are the primary evidence.
| Date | InsiderAn officer or director of a company, or an owner of more than 10% of its shares. The law requires them to report their trades in the company's stock to the SEC. | Role | Shares | Price | Value | Flags | Filing |
|---|---|---|---|---|---|---|---|
| 2021-06-02 | General Atlantic Partners (Bermuda) EU, L.P. history of General Atlantic Partners (Bermuda) EU, L.P.'s purchases | Director | 1,500,000 | $20.00 | $30.0M | SEC filing for General Atlantic Partners (Bermuda) EU, L.P. (opens in a new tab) | |
| 2021-06-02 | GOYAL ARJUN history of GOYAL ARJUN's purchases | Director | 750,000 | $20.00 avg | $15.0M | ||
| 2021-06-02 | GOYAL ARJUN | 20,250 | $20.00 | $405.0K | SEC filing for GOYAL ARJUN (opens in a new tab) | ||
| 2021-06-02 | GOYAL ARJUN | 729,750 | $20.00 | $14.6M | SEC filing for GOYAL ARJUN (opens in a new tab) | ||
| 2021-06-02 | Medicxi Growth I LP 3 purchases with a 63-day result · median -24.2% | 10% owner | 600,000 | $20.00 avg | $12.0M | ||
| 2021-06-02 | Medicxi Growth I LP | 13,923 | $20.00 | $278.5K | SEC filing for Medicxi Growth I LP (opens in a new tab) | ||
| 2021-06-02 | Medicxi Growth I LP | 586,077 | $20.00 | $11.7M | SEC filing for Medicxi Growth I LP (opens in a new tab) | ||
| 2021-06-02 | De Rubertis Francesco 3 purchases with a 63-day result · median -24.2% | Director | 600,000 | $20.00 avg | $12.0M | ||
| 2021-06-02 | De Rubertis Francesco | 586,077 | $20.00 | $11.7M | SEC filing for De Rubertis Francesco (opens in a new tab) | ||
| 2021-06-02 | De Rubertis Francesco | 13,923 | $20.00 | $278.5K | SEC filing for De Rubertis Francesco (opens in a new tab) | ||
| 2021-06-02 | Weinhoff Gregory M history of Weinhoff Gregory M's purchases | CFO | 10,000 | $20.00 | $200.0K | SEC filing for Weinhoff Gregory M (opens in a new tab) | |
| 2021-06-02 | HUSSAIN IQBAL J history of HUSSAIN IQBAL J's purchases | General counsel | 8,500 | $20.00 avg | $170.0K | ||
| 2021-06-02 | HUSSAIN IQBAL J | 3,000 | $20.00 | $60.0K | SEC filing for HUSSAIN IQBAL J (opens in a new tab) | ||
| 2021-06-02 | HUSSAIN IQBAL J | 5,500 | $20.00 | $110.0K | SEC filing for HUSSAIN IQBAL J (opens in a new tab) | ||
| 2021-06-02 | Bush Tia L history of Bush Tia L's purchases | Other C-suite | 3,000 | $20.00 | $60.0K | SEC filing for Bush Tia L (opens in a new tab) | |
| 2021-06-02 | Thorell Marella history of Thorell Marella's purchases | Other C-suite | 1,000 | $20.00 | $20.0K | SEC filing for Thorell Marella (opens in a new tab) | |
| 2021-06-02 | CHAO DAVID M history of CHAO DAVID M's purchases | Other C-suite | 500 | $20.00 | $10.0K | SEC filing for CHAO DAVID M (opens in a new tab) | |
| 2021-06-02 | Templeman Thomas history of Templeman Thomas's purchases | Other C-suite | 250 | $20.00 | $5.0K | SEC filing for Templeman Thomas (opens in a new tab) | |
| Total | $69.5M | ||||||
Other buying runs at CNTA
A buying runPurchases at one company with no pause longer than the cluster rule allows. A long pause ends the run, so one company can have several. ends after a pause in the buying, so one company can have several. Returns are the stock's return minus its benchmarkThe index a stock's return is compared with: a small-cap index for small companies, a large-cap index otherwise. (IWM for small companies, SPY otherwise), from the first open after the buying run became a cluster. Past results, not a forecast.
After this buying run became a cluster, vs benchmark: 21 days -18.0% (-14.9% raw)63 days -13.9% (-6.4% raw)126 days -56.5% (-48.5% raw)
| Window | Insiders | Total | Score | 21 days vs benchmark | 63 days vs benchmark | 126 days vs benchmark | Status |
|---|---|---|---|---|---|---|---|
| 2021-11-16 → 2021-12-02 | 5 | $5.3M | 72 | +5.5% (-0.7% raw) | -12.1% (-27.5% raw) | -41.0% (-64.3% raw) | closed |